Cargando…
Complement C5a induces PD-L1 expression and acts in synergy with LPS through Erk1/2 and JNK signaling pathways
Severe bacterial infection results in both uncontrolled inflammation and immune suppression in septic patients. Although there is ample evidence that complement activation provokes overwhelming pro-inflammatory responses, whether or not it plays a role in immune suppression in this case is unclear....
Autores principales: | An, Ling-Ling, Gorman, Jacob V., Stephens, Geoffrey, Swerdlow, Bonnie, Warrener, Paul, Bonnell, Jessica, Mustelin, Tomas, Fung, Michael, Kolbeck, Roland |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5022031/ https://www.ncbi.nlm.nih.gov/pubmed/27624143 http://dx.doi.org/10.1038/srep33346 |
Ejemplares similares
-
Non-synergy of PD-1 blockade with T-cell therapy in solid tumors
por: Davies, John S, et al.
Publicado: (2022) -
Deubiquitinase Inhibitor b-AP15 Attenuated LPS-Induced Inflammation via Inhibiting ERK1/2, JNK, and NF-Kappa B
por: Zhang, Fangcheng, et al.
Publicado: (2020) -
JNK, p38, ERK, and SGK1 Inhibitors in Cancer
por: Cicenas, Jonas, et al.
Publicado: (2017) -
Downregulation of ROR2 attenuates LPS‐induced A549 cell injury through JNK and ERK signaling pathways
por: Wang, Zhonglin, et al.
Publicado: (2023) -
GLP-2 Attenuates LPS-Induced Inflammation in BV-2 Cells by Inhibiting ERK1/2, JNK1/2 and NF-κB Signaling Pathways
por: Li, Nan, et al.
Publicado: (2016)